Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

HCSG vs DBVT vs ALKS vs AMSF vs PRGO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
HCSG
Healthcare Services Group, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$1.60B
5Y Perf.-6.7%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.-58.8%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.90B
5Y Perf.+116.4%
AMSF
AMERISAFE, Inc.

Insurance - Specialty

Financial ServicesNASDAQ • US
Market Cap$569M
5Y Perf.-50.6%
PRGO
Perrigo Company plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • IE
Market Cap$1.61B
5Y Perf.-78.6%

HCSG vs DBVT vs ALKS vs AMSF vs PRGO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
HCSG logoHCSG
DBVT logoDBVT
ALKS logoALKS
AMSF logoAMSF
PRGO logoPRGO
IndustryMedical - Care FacilitiesBiotechnologyBiotechnologyInsurance - SpecialtyDrug Manufacturers - Specialty & Generic
Market Cap$1.60B$1712.35T$5.90B$569M$1.61B
Revenue (TTM)$1.84B$0.00$1.56B$325M$4.18B
Net Income (TTM)$59M$-168M$153M$46M$-1.82B
Gross Margin13.3%65.4%47.6%34.2%
Operating Margin3.0%12.3%17.8%-4.1%
Forward P/E20.8x24.8x14.4x5.6x
Total Debt$25M$22M$70M$491K$3.97B
Cash & Equiv.$161M$194M$1.12B$62M$532M

HCSG vs DBVT vs ALKS vs AMSF vs PRGOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

HCSG
DBVT
ALKS
AMSF
PRGO
StockMay 20May 26Return
Healthcare Services… (HCSG)10093.3-6.7%
DBV Technologies S.… (DBVT)10041.2-58.8%
Alkermes plc (ALKS)100216.4+116.4%
AMERISAFE, Inc. (AMSF)10049.4-50.6%
Perrigo Company plc (PRGO)10021.4-78.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: HCSG vs DBVT vs ALKS vs AMSF vs PRGO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HCSG and AMSF are tied at the top with 2 categories each (5-stock set) — the right choice depends on your priorities. AMERISAFE, Inc. is the stronger pick specifically for profitability and margin quality and capital preservation and lower volatility. PRGO and DBVT also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
HCSG
Healthcare Services Group, Inc.
The Growth Play

HCSG has the current edge in this matchup, primarily because of its strength in growth exposure.

  • Rev growth 7.1%, EPS growth 52.8%, 3Y rev CAGR 2.8%
  • 7.1% revenue growth vs DBVT's -100.0%
  • 7.3% ROA vs DBVT's -89.0%
Best for: growth exposure
DBVT
DBV Technologies S.A.
The Momentum Pick

DBVT is the clearest fit if your priority is momentum.

  • +110.4% vs PRGO's -51.2%
Best for: momentum
ALKS
Alkermes plc
The Defensive Pick

ALKS is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 1.06, Low D/E 3.8%, current ratio 3.55x
Best for: sleep-well-at-night
AMSF
AMERISAFE, Inc.
The Insurance Pick

AMSF is the #2 pick in this set and the best alternative if long-term compounding and defensive is your priority.

  • 31.8% 10Y total return vs ALKS's -11.0%
  • Beta 0.23, yield 8.4%, current ratio 0.32x
  • 14.3% margin vs PRGO's -43.5%
  • Beta 0.23 vs DBVT's 1.26, lower leverage
Best for: long-term compounding and defensive
PRGO
Perrigo Company plc
The Income Pick

PRGO ranks third and is worth considering specifically for income & stability.

  • Dividend streak 10 yrs, beta 1.18, yield 9.8%
  • Lower P/E (5.6x vs 14.4x)
  • 9.8% yield, 10-year raise streak, vs AMSF's 8.4%, (3 stocks pay no dividend)
Best for: income & stability
See the full category breakdown
CategoryWinnerWhy
GrowthHCSG logoHCSG7.1% revenue growth vs DBVT's -100.0%
ValuePRGO logoPRGOLower P/E (5.6x vs 14.4x)
Quality / MarginsAMSF logoAMSF14.3% margin vs PRGO's -43.5%
Stability / SafetyAMSF logoAMSFBeta 0.23 vs DBVT's 1.26, lower leverage
DividendsPRGO logoPRGO9.8% yield, 10-year raise streak, vs AMSF's 8.4%, (3 stocks pay no dividend)
Momentum (1Y)DBVT logoDBVT+110.4% vs PRGO's -51.2%
Efficiency (ROA)HCSG logoHCSG7.3% ROA vs DBVT's -89.0%

HCSG vs DBVT vs ALKS vs AMSF vs PRGO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

HCSGHealthcare Services Group, Inc.
FY 2025
Dietary Services
55.1%$1.0B
Environmental Services
44.9%$825M
DBVTDBV Technologies S.A.

Segment breakdown not available.

ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
AMSFAMERISAFE, Inc.

Segment breakdown not available.

PRGOPerrigo Company plc
FY 2025
Consumer Self-Care Americas
60.8%$2.6B
Consumer Self-Care International
39.2%$1.7B

HCSG vs DBVT vs ALKS vs AMSF vs PRGO — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLHCSGLAGGINGDBVT

Income & Cash Flow (Last 12 Months)

ALKS leads this category, winning 3 of 6 comparable metrics.

PRGO and DBVT operate at a comparable scale, with $4.2B and $0 in trailing revenue. AMSF is the more profitable business, keeping 14.3% of every revenue dollar as net income compared to PRGO's -43.5%. On growth, ALKS holds the edge at +28.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricHCSG logoHCSGHealthcare Servic…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcAMSF logoAMSFAMERISAFE, Inc.PRGO logoPRGOPerrigo Company p…
RevenueTrailing 12 months$1.8B$0$1.6B$325M$4.2B
EBITDAEarnings before interest/tax$72M-$112M$212M$58M$58M
Net IncomeAfter-tax profit$59M-$168M$153M$46M-$1.8B
Free Cash FlowCash after capex$139M-$151M$392M$8M$108M
Gross MarginGross profit ÷ Revenue+13.3%+65.4%+47.6%+34.2%
Operating MarginEBIT ÷ Revenue+3.0%+12.3%+17.8%-4.1%
Net MarginNet income ÷ Revenue+3.2%+9.8%+14.3%-43.5%
FCF MarginFCF ÷ Revenue+7.6%+25.1%+2.5%+2.6%
Rev. Growth (YoY)Latest quarter vs prior year+6.6%+28.2%+10.3%-7.2%
EPS Growth (YoY)Latest quarter vs prior year+175.0%+91.5%-4.1%-8.5%-56.4%
ALKS leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

PRGO leads this category, winning 6 of 6 comparable metrics.

At 12.3x trailing earnings, AMSF trades at a 55% valuation discount to HCSG's 27.5x P/E. On an enterprise value basis, PRGO's 7.4x EV/EBITDA is more attractive than HCSG's 22.4x.

MetricHCSG logoHCSGHealthcare Servic…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcAMSF logoAMSFAMERISAFE, Inc.PRGO logoPRGOPerrigo Company p…
Market CapShares × price$1.6B$1712.35T$5.9B$569M$1.6B
Enterprise ValueMkt cap + debt − cash$1.5B$1712.35T$4.9B$508M$5.1B
Trailing P/EPrice ÷ TTM EPS27.54x-0.76x24.76x12.27x-1.14x
Forward P/EPrice ÷ next-FY EPS est.20.83x14.42x5.56x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple22.38x17.25x8.53x7.42x
Price / SalesMarket cap ÷ Revenue0.87x4.00x1.80x0.38x
Price / BookPrice ÷ Book value/share3.19x0.66x3.28x2.30x0.55x
Price / FCFMarket cap ÷ FCF11.49x12.28x63.83x11.12x
PRGO leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

AMSF leads this category, winning 5 of 9 comparable metrics.

HCSG delivers a 11.8% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-130 for DBVT. AMSF carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to PRGO's 1.35x. On the Piotroski fundamental quality scale (0–9), HCSG scores 7/9 vs PRGO's 4/9, reflecting strong financial health.

MetricHCSG logoHCSGHealthcare Servic…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcAMSF logoAMSFAMERISAFE, Inc.PRGO logoPRGOPerrigo Company p…
ROE (TTM)Return on equity+11.8%-130.2%+8.8%+9.7%-50.7%
ROA (TTM)Return on assets+7.3%-89.0%+5.4%+5.6%-19.8%
ROICReturn on invested capital+9.0%+18.9%+21.9%+3.7%
ROCEReturn on capital employed+7.7%-145.7%+14.2%+16.8%+4.3%
Piotroski ScoreFundamental quality 0–974774
Debt / EquityFinancial leverage0.05x0.13x0.04x0.00x1.35x
Net DebtTotal debt minus cash-$136M-$172M-$1.0B-$61M$3.4B
Cash & Equiv.Liquid assets$161M$194M$1.1B$62M$532M
Total DebtShort + long-term debt$25M$22M$70M$491,000$4.0B
Interest CoverageEBIT ÷ Interest expense33.02x-189.82x32.30x-7.20x
AMSF leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

HCSG leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in ALKS five years ago would be worth $16,091 today (with dividends reinvested), compared to $3,090 for DBVT. Over the past 12 months, DBVT leads with a +110.4% total return vs PRGO's -51.2%. The 3-year compound annual growth rate (CAGR) favors HCSG at 14.1% vs PRGO's -25.2% — a key indicator of consistent wealth creation.

MetricHCSG logoHCSGHealthcare Servic…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcAMSF logoAMSFAMERISAFE, Inc.PRGO logoPRGOPerrigo Company p…
YTD ReturnYear-to-date+28.6%+4.9%+25.3%-18.3%-13.5%
1-Year ReturnPast 12 months+55.8%+110.4%+16.5%-29.2%-51.2%
3-Year ReturnCumulative with dividends+48.6%+19.7%+14.5%-24.8%-58.1%
5-Year ReturnCumulative with dividends-21.1%-69.1%+60.9%-18.9%-60.1%
10-Year ReturnCumulative with dividends-26.8%-87.0%-11.0%+31.8%-77.7%
CAGR (3Y)Annualised 3-year return+14.1%+6.2%+4.6%-9.1%-25.2%
HCSG leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ALKS and AMSF each lead in 1 of 2 comparable metrics.

AMSF is the less volatile stock with a 0.23 beta — it tends to amplify market swings less than DBVT's 1.26 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 96.7% from its 52-week high vs PRGO's 41.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricHCSG logoHCSGHealthcare Servic…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcAMSF logoAMSFAMERISAFE, Inc.PRGO logoPRGOPerrigo Company p…
Beta (5Y)Sensitivity to S&P 5001.12x1.26x1.06x0.23x1.18x
52-Week HighHighest price in past year$24.39$26.18$36.60$48.54$28.44
52-Week LowLowest price in past year$12.66$7.53$25.17$29.42$9.23
% of 52W HighCurrent price vs 52-week peak+91.5%+76.3%+96.7%+62.4%+41.2%
RSI (14)Momentum oscillator 0–10061.848.160.234.260.9
Avg Volume (50D)Average daily shares traded676K252K2.3M212K3.4M
Evenly matched — ALKS and AMSF each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — HCSG and PRGO each lead in 1 of 2 comparable metrics.

Analyst consensus: HCSG as "Hold", DBVT as "Buy", ALKS as "Buy", AMSF as "Buy", PRGO as "Hold". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs 9.8% for HCSG (target: $25). For income investors, PRGO offers the higher dividend yield at 9.81% vs AMSF's 8.41%.

MetricHCSG logoHCSGHealthcare Servic…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcAMSF logoAMSFAMERISAFE, Inc.PRGO logoPRGOPerrigo Company p…
Analyst RatingConsensus buy/hold/sellHoldBuyBuyBuyHold
Price TargetConsensus 12-month target$24.50$46.33$44.00$44.50$20.00
# AnalystsCovering analysts151528636
Dividend YieldAnnual dividend ÷ price+8.4%+9.8%
Dividend StreakConsecutive years of raises2000010
Dividend / ShareAnnual DPS$2.55$1.15
Buyback YieldShare repurchases ÷ mkt cap+3.9%0.0%+0.5%+2.1%0.0%
Evenly matched — HCSG and PRGO each lead in 1 of 2 comparable metrics.
Key Takeaway

ALKS leads in 1 of 6 categories (Income & Cash Flow). PRGO leads in 1 (Valuation Metrics). 2 tied.

Best OverallHealthcare Services Group, … (HCSG)Leads 1 of 6 categories
Loading custom metrics...

HCSG vs DBVT vs ALKS vs AMSF vs PRGO: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is HCSG or DBVT or ALKS or AMSF or PRGO a better buy right now?

For growth investors, Healthcare Services Group, Inc.

(HCSG) is the stronger pick with 7. 1% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). AMERISAFE, Inc. (AMSF) offers the better valuation at 12. 3x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — HCSG or DBVT or ALKS or AMSF or PRGO?

On trailing P/E, AMERISAFE, Inc.

(AMSF) is the cheapest at 12. 3x versus Healthcare Services Group, Inc. at 27. 5x. On forward P/E, Perrigo Company plc is actually cheaper at 5. 6x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — HCSG or DBVT or ALKS or AMSF or PRGO?

Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +60.

9%, compared to -69. 1% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: AMSF returned +31. 8% versus DBVT's -87. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — HCSG or DBVT or ALKS or AMSF or PRGO?

By beta (market sensitivity over 5 years), AMERISAFE, Inc.

(AMSF) is the lower-risk stock at 0. 23β versus DBV Technologies S. A. 's 1. 26β — meaning DBVT is approximately 444% more volatile than AMSF relative to the S&P 500. On balance sheet safety, AMERISAFE, Inc. (AMSF) carries a lower debt/equity ratio of 0% versus 135% for Perrigo Company plc — giving it more financial flexibility in a downturn.

05

Which is growing faster — HCSG or DBVT or ALKS or AMSF or PRGO?

By revenue growth (latest reported year), Healthcare Services Group, Inc.

(HCSG) is pulling ahead at 7. 1% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: Healthcare Services Group, Inc. grew EPS 52. 8% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, ALKS leads at 9. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — HCSG or DBVT or ALKS or AMSF or PRGO?

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMSF leads at 18. 6% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is HCSG or DBVT or ALKS or AMSF or PRGO more undervalued right now?

On forward earnings alone, Perrigo Company plc (PRGO) trades at 5.

6x forward P/E versus 20. 8x for Healthcare Services Group, Inc. — 15. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DBVT: 131. 8% to $46. 33.

08

Which pays a better dividend — HCSG or DBVT or ALKS or AMSF or PRGO?

In this comparison, PRGO (9.

8% yield), AMSF (8. 4% yield) pay a dividend. HCSG, DBVT, ALKS do not pay a meaningful dividend and should not be held primarily for income.

09

Is HCSG or DBVT or ALKS or AMSF or PRGO better for a retirement portfolio?

For long-horizon retirement investors, AMERISAFE, Inc.

(AMSF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 23), 8. 4% yield). Both have compounded well over 10 years (AMSF: +31. 8%, DBVT: -87. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between HCSG and DBVT and ALKS and AMSF and PRGO?

These companies operate in different sectors (HCSG (Healthcare) and DBVT (Healthcare) and ALKS (Healthcare) and AMSF (Financial Services) and PRGO (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: HCSG is a small-cap quality compounder stock; DBVT is a mega-cap quality compounder stock; ALKS is a small-cap quality compounder stock; AMSF is a small-cap deep-value stock; PRGO is a small-cap income-oriented stock. AMSF, PRGO pay a dividend while HCSG, DBVT, ALKS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

HCSG

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

AMSF

Income & Dividend Stock

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 8%
Run This Screen
Stocks Like

PRGO

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 20%
  • Dividend Yield > 3.9%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.